Though the combined loss of TP53 and RB1 is not sufficient to uniformly induce neuroendocrine phenotypes in prostate carcinoma, it is nevertheless interesting that disruption of RB1 expression in nerve cells in vitro has been shown to enhance the growth of nerve cells and adult nerve regeneration [9,44]. Here, RB1 is linked to prostate carcinoma.